Unichem gets USFDA nod to commercialise Amiodarone tablets
Unichem gets USFDA nod to commercialise Amiodarone tablets

Unichem gets USFDA nod to commercialise Amiodarone tablets

Anthony Fernandes Article rating: 4.4

The shares of Unichem Laboratories surged almost 3 per cent from its day’s low on Wednesday after the company announced that it has received abbreviated new drug application (ANDA) approval from United States Food and Drug Administration (USFDA) to market its Amiodarone tablets, USP, 200 mg.

Strong advances growth help Axis Bank gain 5 per cent on BSE
Strong advances growth help Axis Bank gain 5 per cent on BSE

Strong advances growth help Axis Bank gain 5 per cent on BSE

Pratik Shastri Article rating: 4.7

In addition to this, the bank also reported advances growth of 13 per cent on YoY basis. The advances in the balance sheet of the bank show the total amount of credit it has till the accounting date.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.9

The market opened in the red on July 22, 2020, overall volumes in futures & options currently stand at 2,07,57,764 crore contracts with a turnover of Rs. 13,17,023.27 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 4.0

The market opened in the red on July 22, 2020, overall volumes in futures & options currently stand at 2,07,57,764 crore contracts with a turnover of Rs. 13,17,023.27 crore.

RSS
First20672068206920702072207420752076Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR